Abstract

GOMEZ-GARCIA, Diego Mauricio  and  GARCIA-PERDOMO, Herney Andrés. Medical cannabis: Critical points for clinical application. Biomed. [online]. 2022, vol.42, n.3, pp.450-459.  Epub Sep 02, 2022. ISSN 0120-4157.  https://doi.org/10.7705/biomedica.6468.

Since ancient times cannabis has been used for recreational and medicinal purposes. It is a significant source of chemical compounds, most of them called phytocannabinoids. These compounds have several physiological effects and produce their effects primarily by binding to endogenous cannabinoid receptors such as CB1 and CB2, among others.

Cannabis has potential therapeutic properties and its preparations have been used as traditional remedies to treat pain and emesis. Synthetic cannabinoids are used clinically as analgesics, antispastics, antiemetics, and appetite stimulants. Significant cannabis toxicity is rare in adults; however, it can produce countless acute and chronic side effects.

The quality of the evidence in this field is limited by the short duration of the trials, poor sample sizes, lack of a control group, and the existence of bias in most of the reviewed studies. Therefore, a larger number of studies with better methodological quality is required to support the safe use of this therapy. The decision to include cannabinoids as a treatment for any of the conditions described will depend on the evidence, the use of previous therapies, and the type of patient.

Keywords : Cannabis; cannabinoids; endocannabinoids; efficacy; safety; therapeutics uses.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )